Stockscreener 앱 받기
5.00
1.21%
0.05
전일 마감가:
$4.95
열려 있는:
$4.87
하루 거래량:
580.52K
Relative Volume:
0.13
시가총액:
$1.78B
수익:
$9.68M
순이익/손실:
$-250.64M
주가수익비율:
-3.5719
EPS:
-1.3998
순현금흐름:
$-89.83M
1주 성능:
-5.83%
1개월 성능:
+5.92%
6개월 성능:
+13.61%
1년 성능:
+175.27%
1일 변동 폭
$4.81
$5.045
1주일 범위
$4.81
$5.26
52주 변동 폭
$1.47
$6.04
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
4.995 | 1.76B | 9.68M | -250.64M | -89.83M | -1.3998 |
VRTX
Vertex Pharmaceuticals Inc
|
490.79 | 123.36B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
684.76 | 71.18B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.38 | 53.68B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
182.37 | 38.09B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
277.14 | 37.80B | 4.29B | 577.22M | 641.34M | 4.2086 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-03-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
Precigen Inc. (PGEN) Slides 2.64% as Stock Tests Key Support LevelsMutual Fund Flow - dars.gov.et
Precigen (PGEN) Proxy Filing Summary - Quartr
What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors? - The Motley Fool
What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors? - The Motley Fool
Precigen Inc. (PGEN) Eases Slightly, Holding Above Key SupportBreadth Thrust - dars.gov.et
Precigen (PGEN) In Focus As Russell Removal Tests Its Undervalued Narrative - simplywall.st
Precigen, Inc. (PGEN) is a great momentum stock: Should you buy? - MSN
Precigen Inc (NASDAQ:PGEN) Flashes Perfect Technical Rating and Explosive Sales Growth in Minervini Screen - ChartMill
Precigen Inc. (PGEN) Edges Higher in Low-Volume Trade, Tech Support HoldsRelative Volume - DonanımHaber
Precigen Inc. (PGEN) Edges Higher as Biotech Sector Attention IntensifiesMotive Wave - dars.gov.et
Precigen reports $3.4M in PAPZIMEOS sales for Q4 2025 - Investing.com
PGENPrecigen Inc Latest SEC Filings - Finviz
Precigen Insider Sold Shares Worth $2,042,864, According to a Recent SEC Filing - marketscreener.com
Precigen Insider Sold Shares Worth $1,113,143, According to a Recent SEC Filing - Moomoo
Precigen CFO Harry Thomasian Jr. sells $1.1m in company stock - Investing.com UK
Insider Sell Alert: Harry Thomasian Sells 200,000 Shares of Prec - GuruFocus
Precigen CEO Helen Sabzevari sells $2.04m in PGEN stock - Investing.com
Precigen COO Rutul Shah sells $251,105 in company stock - Investing.com
Precigen (PGEN) COO sells 42,924 shares after option exercise - Stock Titan
Precigen COO Rutul Shah sells $251,105 in company stock By Investing.com - Investing.com South Africa
Form 4 Precigen Inc For: 1 July By Investing.com - Investing.com Nigeria
Precigen CEO Helen Sabzevari sells $2.04m in PGEN stock By Investing.com - Investing.com India
[Form 4] PRECIGEN, INC. Insider Trading Activity - Stock Titan
Precigen (PGEN) CFO executes 200,000-share open-market sale under 10b5-1 plan - Stock Titan
Form 144 PRECIGEN For: 1 July By Investing.com - Investing.com Nigeria
PGEN (NASDAQ) affiliate files Rule 144 notice to sell 28,571 shares - Stock Titan
Does Precigen’s (PGEN) Russell Value Index Exit Signal a Shifting Investor Base or Story? - simplywall.st
[144] PRECIGEN, INC. SEC Filing - Stock Titan
Form 144 PRECIGEN For: 29 June By Investing.com - Investing.com South Africa
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 2000 Value Benchmark - marketscreener.com
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 2500 Value Benchmark - marketscreener.com
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Precigen: Entering The Oncology "Sweet Spot" (NASDAQ:PGEN) - Seeking Alpha
PGEN Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Precigen, Inc. – NASDAQ:PGEN - TradingView
Precigen Inc Actuals & Estimates (BX:I5X) - TradingView
Price to earnings forward of Precigen, Inc. – NASDAQ:PGEN - TradingView
Precigen Shareholders Expand Incentive Plan, Reaffirm Governance - The Globe and Mail
Precigen (PGEN) investors back 7M-share incentive pool and all board picks - Stock Titan
Clearfield And 2 Insider Picks For Strong Growth - simplywall.st
Precigen (PGEN) Is Up 12.1% After Orphan Exclusivity Win for PAPZIMEOS TherapyWhat's Changed - Sahm
Precigen stock hits 52-week high at 5.47 USD By Investing.com - Investing.com Australia
Precigen stock hits 52-week high at 5.47 USD - Investing.com
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Precigen Inc 주식 (PGEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Thomasian Harry Jr. | Chief Financial Officer |
Jun 29 '26 |
Sale |
5.78 |
28,571 |
165,140 |
525,964 |
| Shah Rutul R | Chief Operating Officer |
Jun 29 '26 |
Option Exercise |
2.33 |
42,924 |
100,013 |
540,675 |
| Shah Rutul R | Chief Operating Officer |
Jun 29 '26 |
Sale |
5.85 |
42,924 |
251,105 |
497,751 |
| Sabzevari Helen | President and CEO |
Jun 29 '26 |
Option Exercise |
2.33 |
346,836 |
808,128 |
4,115,708 |
| Sabzevari Helen | President and CEO |
Jun 29 '26 |
Sale |
5.89 |
346,836 |
2,042,864 |
3,768,872 |
0.34%
0.55%
자본화:
|
볼륨(24시간):